Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Proceedings of the National Academy of Sciences

Topics

Biology

Epidemiology

Medicine

Immunology

Microbiology

Show all topics

DOI

10.1073/pnas.2014441117

License

CC-BY

Other Formats

PDF